Top compounds associated with response to ZNF865


Feature Type Standardized
Nominal ANOVA
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.1 0.006
mRNA Doxorubicin gCSI pan-cancer AAC -0.14 0.006
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.095 0.007
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC -0.091 0.008
mRNA BRD4132 CTRPv2 pan-cancer AAC -0.1 0.009
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.095 0.01
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.01
mRNA L-685458 CCLE pan-cancer AAC -0.11 0.01
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.089 0.01
Download CSV